chartexchange

NUVB
Nuvation Bio Inc.
stockNYSE

At CloseNov 18, 2026 3:59:56 PM EST
3.77USD-3.333%(-0.13)5,957,153
Pre-marketNov 18, 2026 8:42:30 AM EST
3.90USD0.000%(0.00)
After-hoursNov 18, 2026 4:21:30 PM EST
3.7891USD+0.507%(+0.0191)
Loading…
Loading…
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$3.90
Beta
1.64
52-Week High
$9.75 2025-12-22
52-Week Low
$3.77 2026-11-18
SMA 50
$4.96
SMA 200
$5.30
Avg. Vol 10D
5.40M
Avg. Vol 30D
5.25M
Avg. Vol 90D
5.47M
Relative Vol
1.14
353.02M
253.34M
61,999,741
0.3300%
1,500,000
1,087,115
1,087,115
NUVB Profile

nuvation bio is a biopharmaceutical company focused on revolutionizing cancer treatment by discovering, developing and delivering therapies that tackle some of the greatest needs in oncology. nuvation bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. nuvation bio was founded in 2018 by biopharma industry veteran david hung, m.d., who previously founded medivation, inc., which brought to patients one of the world's leading prostate cancer medicines. nuvation bio has offices in new york and san francisco.

NUVB Performance
PeriodPriceDateChangeBeta
1W4.062026-11-12-7.14%0.523
1M4.482026-10-19-15.85%2.018
3M7.262026-08-19-48.07%1.959
6M4.242026-05-19-11.09%1.624
1Y7.152025-11-19-47.27%1.641
2Y2.592024-11-19+45.56%—
5Y9.052021-11-19-58.34%1.386
NUVB Stock Summary

Nuvation Bio Inc. (NYSE:NUVB) stock price today is $3.77, and today's volume is 5,957,153. NUVB is down 3.333% today. The 30 day average volume is 5.25M. NUVB market cap is $1.33B with 353.02M shares outstanding.